9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 23 Sept, 15:13 UTC

Frustrated by a slump that’s seen Europe lose ground to the U.S. and China, several top drugmakers are calling for speedier clinical trials, intellectual property protections and “fiscal flexibility.”